ArticleAnnals of hematology2023

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.

Yingying Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.